Skip to main content
Premium Trial:

Request an Annual Quote

New Products: CTGT's Connective Tissue Gene Tests

Premium

Connective Tissue Gene Tests (CTGT) has added 12 new assays to its menu of molecular diagnostics for inherited disorders affecting connective tissues.

The Allentown, Pa.-based company is now offering microarray, Sanger sequencing, and next-generation sequencing-based tests for genes associated with Adams-Oliver syndrome, cerebral cavernous malformations, cutis laxa, multiple self-healing squamous epithelioma, opsismodysplasia, and supervalvular aortic stenosis.

The pricing of CTGT's new tests depends on the technology used and the number of genes assessed. For its array-based tests, the company relies on its High-Density Targeted Array platform, an Agilent Technologies-manufactured chip for copy number variation detection.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.